When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RHHBY - Aggressive Strides Forward For Moderna's Cancer Vaccine
Roche Holding Ltd ADR
2024-05-20 17:17:41 ET
Summary
Moderna's individualized neoantigen therapy, mRNA-4157, is a cancer vaccine with potential in multiple cancer types.
mRNA-4157 has produced compelling results in stage III/IV melanoma patients, where a combination with pembrolizumab reduced the risk of recurrence or death by 49%, relative to pembrolizumab alone.
Competition exists from BioNTech and Roche's autogene cevumeran, another cancer vaccine, where a readout from a melanoma trial could come in H2'24.